Barnabas Health Latest to Settle ERISA Suit

A settlement has been struck in an ERISA lawsuit involving the New Jersey-based health care provider a little more than a year after a judge allowed the case to proceed past the defense’s motion to dismiss.

In April 2021, the U.S. District Court for the District of New Jersey denied the dismissal of an Employee Retirement Income Security Act lawsuit against Barnabas Health.

Never miss a story — sign up for PLANADVISER newsletters to keep up on the latest retirement plan adviser news.

Now, a little more than a year later, the parties in the lawsuit have filed a settlement agreement that would see Barnabas Health, via its fiduciary insurer, pay $1.75 million to resolve the litigation, which involves two defined contribution retirement plans offered to employees. As stipulated in the text of the agreement, one-third of this amount may be used to cover the plaintiffs’ attorney fees.

In the original complaint, the plaintiffs alleged that the plans’ fiduciaries chose high-cost investments when lower-cost alternatives were available. They also suggested that the fiduciaries selected higher-cost share classes for funds when lower-cost share classes were available, and that there were lower-cost alternative funds available that performed better over the long-term. Finally, the lawsuit alleged that the fiduciaries failed to monitor or control the plans’ recordkeeping expenses.

In their motions to dismiss the case, the Barnabas defendants argued that the plaintiffs invested in only some of the funds cited, and that they lacked standing to press claims based on the funds in which they did not invest. The court’s prior order rejecting the defense’s dismissal motion found that the participants had sufficiently alleged an injury to their own investments by virtue of the fiduciaries’ mismanagement to have standing in the case.

Beyond the settlement payment of $1.75 million, the settlement agreement also includes a requirement that the Barnabas defendants conduct a request for proposals process regarding the plans’ recordkeeping fees and services. This must be done within 18 months of the effective settlement date.

Notably, the settlement agreement emphasizes that Barnabas Health does not admit any wrongdoing or legal liability of any kind, whether legal or factual. The defendants state that they are entering into the settlement agreement only to eliminate the burden and expense of further litigation.

According to expert ERISA attorneys, the challenging economics of ERISA litigation have caused many defendants to follow the route now being taken by Barnabas, wherein they pay sizable settlement agreements while maintaining that they did not commit the alleged fiduciary breaches. When an employer faces a class action ERISA lawsuit that clears a motion to dismiss, the choice for the plan sponsors is either to continue to fight the litigation, which often becomes incredibly expensive, or to pay to settle a claim that might only involve a couple of million dollars. Attorneys also note that, as in this case, input from insurance carriers is a definite consideration in whether a case settles.

The full text of the settlement agreement is available here.

‘Massive’ Fraud Charges Trigger Allianz Global Investors U.S. Sale to Voya

The SEC says the charges and settlement show even the most sophisticated institutional investors, like pension funds, can become victims of wrongdoing.

Allianz Global Investors U.S., the U.S.-based asset management arm of German insurer Allianz SE, has settled charges from the Securities and Exchange Commission that the firm and three former senior portfolio managers conducted what the SEC called “a massive fraudulent scheme” that cost investors more than $5 billion in losses.

Never miss a story — sign up for PLANADVISER newsletters to keep up on the latest retirement plan adviser news.

The scheme involved a trading strategy called “Structured Alpha,” which used complex options trading to earn returns for investors. However, the perpetrators of the scam did not reveal the potential immense downside risks of this trading strategy to investors. In March 2020, when the COVID-19 pandemic caused markets to crash, the losses were dramatic. Approximately 114 institutional investors bought the investment product and paid more than $550 million in fees, according to the SEC press release.

“This case once again demonstrates that even the most sophisticated institutional investors, like pension funds, can become victims of wrongdoing,” said SEC Chairman Gary Gensler in the commission’s release. “Unfortunately, we’ve seen a recent string of cases in which derivatives and complex products have harmed investors across market sectors.”

Allianz Global Investors has agreed to pay billions of dollars as part of an integrated global resolution, including more than $1 billion to settle SEC charges and, together with its parent, Allianz SE, over $5 billion in restitution to victims, according to the commission.

As a consequence of pleading guilty, AGI U.S. is automatically and immediately disqualified from providing advisory services to U.S.-registered investment funds for the next ten years and will exit the business. 

As a result of the ban, Allianz SE plans to sell most of the U.S. piece of Allianz Global Investors to Voya Financial Inc.

Voya Investment Management will add about $120 billion of assets under management as well as some investment teams, the company said in a statement Tuesday. Allianz will take a 24% stake in Voya IM. 

The funds will transition over a period of up to ten weeks for the U.S. mutual funds that AGI U.S. sub-advises and four months for the U.S. closed-end funds that AGI U.S. advises, according to the SEC.

The institutional investors that sued or filed complaints against Allianz include the Arkansas Teacher Retirement System, the Employees’ Retirement System of Milwaukee, San Diego City Employees’ Retirement, Chicago Laborers Pension and Welfare Funds, Raytheon, Blue Cross Blue Shield, the Metropolitan Transit Authority Pension Funds and the J. Paul Getty Trust.

The SEC’s complaint, filed in the U.S. District Court in Manhattan, alleges that Structured Alpha’s lead portfolio manager, Gregoire P. Tournant, orchestrated the multi-year scheme to mislead investors who invested approximately $11 billion in Structured Alpha. The SEC’s complaint further alleges that, with assistance from Co-Lead Portfolio Manager Trevor L. Taylor and Portfolio Manager Stephen G. Bond-Nelson, Tournant manipulated numerous financial reports and other information provided to investors to conceal the magnitude of Structured Alpha’s true risk and the funds’ actual performance.

AGI U.S. admitted that its conduct violated the federal securities laws and agreed to a cease-and-desist order, a censure and payment of $315.2 million in disgorgement, $34 million in prejudgment interest and a $675 million civil penalty, a portion of which will be distributed to certain investors, with the amount of disgorgement and prejudgment interest deemed satisfied by amounts it paid to the U.S. Department of Justice as part of an integrated global resolution. In a parallel criminal proceeding, the U.S. Attorney’s Office for the Southern District of New York today announced criminal charges for similar conduct against AGI U.S., Tournant, Taylor and Bond-Nelson. As part of the parallel criminal proceeding, AGI U.S., Taylor and Bond-Nelson have agreed to guilty pleas. 

AGI U.S. deliberately increased risk levels in its portfolio in late February and early March in order to “recoup” losses that had already occurred earlier in the year, according to information available on the website of Litowitz Berger & Grossman, a law firm leading the litigation on behalf of multiple institutional investors.

In their filing against AGI U.S., San Diego City Employees’ Retirement System claimed the portfolio’s positions left the fund dangerously exposed to even the slightest increase in market volatility or decline in equity prices—the very conditions that Allianz economists, and many others, warned were on the immediate horizon.”

Allianz had marketed Strategic Alpha Funds as safe investments that would be protected from risk in multiple different scenarios.

“The Alpha Funds’ purportedly unique ‘alpha’ component—the actively managed options strategy overlay—was supposed to provide investors with downside protection and possible upside in both bull and bear equity markets, and in times of both high and low volatility,” according to the documents the San Diego retirement system filed in December 2020 to the Supreme Court of the State of New York.

Staff at AGI U.S. manipulated performance and risk data by deliberately changing the numbers in their reports to investors, according to SEC complaints. In one risk report, the defendants reduced the potential losses by changing “negative 42.1505489755747%” to “negative 4.1505489755747%,” according to the SEC.

Once the pandemic hit and losses became more severe, AGI U.S. once again allegedly engaged in data manipulation. Losses reported to investors were reduced. On one particular day, Allianz reported a “-9.2607085709004%” return to its investors instead of the true figure of “-18.2607085709004%,” alleges the SEC complaint.

The SEC’s press release also states that the three senior portfolio managers continued to lie to SEC staff after they began investigating the matter.

“Following the crash of the Structured Alpha Funds, the defendants continued their pattern of deceit by lying to SEC staff, and their fraud would have gone undetected if it weren’t for the persistence of SEC lawyers who pieced together the full scope of the massive fraud,” stated Gurbir S. Grewal, director of the SEC’s Division of Enforcement.

«